Suppr超能文献

Kruppel 样因子 4 和 5 的表达与乳腺癌临床表现的关系。

Association of expression of kruppel-like factor 4 and kruppel-like factor 5 with the clinical manifestations of breast cancer.

机构信息

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, 250 Wu-Xing Street, Taipei, 110, Taiwan.

出版信息

Pathol Oncol Res. 2012 Apr;18(2):161-8. doi: 10.1007/s12253-011-9422-7. Epub 2011 Jun 15.

Abstract

Kruppel-like factors (KLFs) are import modulators of cell proliferation, differentiation, and transformation and have recently been considered possible prognostic factors in breast cancer. In this study, we investigated the correlation between KLF4 and KLF5 expression and the clinical manifestations of breast cancer by immunohistochemical analysis. We observed increased KLF4 and KLF5 expression in tumor cells (invasive and in situ carcinomas), consistent KLF4 and KLF5 expression in in situ and invasive carcinomas, significant associations between KLF4 expression and tumor grade (p = 0.033), size (p = 0.035) and stage (p = 0.006), and an association between KLF5 expression and tumor grade (p = 0.033). Interestingly, we observed a relationship between increasing age and KLF4 expression (p = 0.007), with a tendency towards greater expression in tumor cells in patients over 50 years old. Moreover, KLF5 nuclear localization was restricted to non-tumor breast ducts and lobules; however, loss of nuclear expression of KLF5 in in situ and invasive carcinomas was observed. Although the mechanism of the loss of KLF5 nuclear expression is not clear, this phenomenon may imply a possible tumor-suppressor-like role for KLF5 in breast cancer tumorigenesis. The expression of KLF4 and KLF5 in breast cancer patients in Taiwan is similar to that in Western countries, except for the uncertainty surrounding its prognostic significance. Further clarification of the underlying mechanisms of KLF4 and KLF5 expression and their correlations with breast cancer outcomes is necessary.

摘要

Kruppel 样因子(KLFs)是细胞增殖、分化和转化的重要调节因子,最近被认为是乳腺癌的可能预后因素。在这项研究中,我们通过免疫组织化学分析研究了 KLF4 和 KLF5 表达与乳腺癌临床表现之间的相关性。我们观察到肿瘤细胞(浸润性和原位癌)中 KLF4 和 KLF5 的表达增加,原位癌和浸润性癌中 KLF4 和 KLF5 的表达一致,KLF4 表达与肿瘤分级(p=0.033)、大小(p=0.035)和分期(p=0.006)之间存在显著相关性,KLF5 表达与肿瘤分级(p=0.033)之间存在相关性。有趣的是,我们观察到 KLF4 表达与年龄增加之间存在关系(p=0.007),年龄超过 50 岁的患者肿瘤细胞中 KLF4 表达倾向于增加。此外,KLF5 的核定位仅限于非肿瘤性乳腺导管和小叶;然而,在原位癌和浸润性癌中观察到 KLF5 的核表达缺失。尽管 KLF5 核表达缺失的机制尚不清楚,但这种现象可能意味着 KLF5 在乳腺癌发生中可能具有肿瘤抑制样作用。台湾乳腺癌患者中 KLF4 和 KLF5 的表达与西方国家相似,除了其预后意义的不确定性。有必要进一步阐明 KLF4 和 KLF5 表达的潜在机制及其与乳腺癌结局的相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验